|Articles|May 1, 2002

May 2002
Volume 8
Issue 5

How Acceptable Are Financial Incentives and Written Feedback for Improving Hypertension Control? Perspectives from Physicians, Clinic Administrators, and Patients

Author(s)Sharon J. Rolnick, PhD, Karen L. Margolis, MD, MPH, Kristine K. Fortman, PhD

Download PDF: How Acceptable Are Financial Incentives and Written Feedback for Improving Hypertension Control? Perspectives from Physicians, Clinic Administrators, and Patients

Articles in this issue

almost 24 years ago

Article

Is Quality Free? The Relationship Between Cost and Quality Across 18 Provider Groups

almost 24 years ago

Article

Bridging the Electronic Divide: Patient and Provider Perspectives on E-mail Communication in Primary Care

almost 24 years ago

Article

Identifying Cost Management Strategies in Dialysis Clinics: Sustainable Savings With Positive Outcomes

almost 24 years ago

Article

The SF-36 General Health Status Survey Documents the Burden of Osteoarthritis and the Benefits of Total Joint Arthroplasty: But Why Should We Use It?

almost 24 years ago

Article

Current Indications for ACE Inhibitors and HOPE for the Future

almost 24 years ago

Article

Is Quality Free? It Depends

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Latest CME

Online Article

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

2.0 Credits / General Pharmacy

AJMC Supplement

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

2.0 Credits / Pain Management

How Acceptable Are Financial Incentives and Written Feedback for Improving Hypertension Control? Perspectives from Physicians, Clinic Administrators, and Patients

Articles in this issue

Newsletter

Related Content

Quality of Life: The Pending Outcome in Idiopathic Pulmonary Fibrosis

Increased Payments to Medicare Advantage Plans for Dually Eligible Beneficiaries

The Health Information Technology Special Issue: Tracking Expansion Across Settings, Technologies, and Stakeholders

Building Trust: Public Priorities for Health Care AI Labeling

Ambient AI Tool Adoption in US Hospitals and Associated Factors

Latest CME

Innovations in Medicine: 2024 Lineup of New and Approved Specialty Drugs

Revolutionizing Acute Pain Relief: Emerging Nonopioid Therapies and the Essential Role of Managed Care

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

How Do GLP-1 Agonists Fit Into Stroke Care?

Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD

Aligning Treatment Goals in IgA Nephropathy: Applying KDIGO’s Dual-Pathway Framework to Clinical Decision-Making

5 Things to Know About the Oral GLP-1 Era